Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 8.30M P/E 1.19 EPS this Y - Ern Qtrly Grth -
Income 3.06M Forward P/E -1.25 EPS next Y - 50D Avg Chg -11.00%
Sales 23.79M PEG - EPS past 5Y - 200D Avg Chg -16.00%
Dividend N/A Price/Book 0.55 EPS next 5Y - 52W High Chg -70.00%
Recommedations 3.00 Quick Ratio 1.63 Shares Outstanding 8.65M 52W Low Chg 52.00%
Insider Own 45.04% ROA 7.36% Shares Float 7.81M Beta 1.23
Inst Own 9.80% ROE 56.40% Shares Shorted/Prior 151.66K/183.39K Price 0.96
Gross Margin 17.62% Profit Margin 12.88% Avg. Volume 39,617 Target Price -
Oper. Margin 13.49% Earnings Date May 1 Volume 18,902 Change -0.91%
About Exicure, Inc.

Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

XCUR Chatroom

User Image Bidzill Posted - 9 hours ago

$XCUR

User Image Marcus2105 Posted - 04/30/24

$XCUR

User Image Nostradamus7777 Posted - 04/29/24

$XCUR is there a reverse split planned for xcur?

User Image Marcus2105 Posted - 04/29/24

$XCUR

User Image Marcus2105 Posted - 04/27/24

$XCUR

User Image Marcus2105 Posted - 04/26/24

$XCUR

User Image AntKnee Posted - 04/26/24

$XCUR

User Image Marcus2105 Posted - 04/24/24

$XCUR

User Image Marcus2105 Posted - 04/22/24

$XCUR

User Image DonCorleone77 Posted - 04/22/24

$XCUR Exicure receives Nasdaq delinquency notice Exicure announced it received a notice of non-compliance from Nasdaq Stock Market LLC on April 17, 2024 notifying the Company that, as a result of the Company's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2023, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission. The Letter states that the Company must submit an update to its original plan to regain compliance with respect to the filing requirements. The plan initially related to the Company's delinquency in filing its Form 10-Q for the quarter ended September 30, 2023, and the Nasdaq staff granted an exception giving the Company until May 20, 2024 to file the third quarter Form 10-Q. Any additional exceptions to allow the Company to regain compliance with all delinquent filings (both the third quarter Form 10-Q and the Form 10-K) will be limited to May 20, 2024.

User Image Stock_Titan Posted - 04/22/24

$XCUR Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K https://www.stocktitan.net/news/XCUR/exicure-inc-received-nasdaq-delinquency-notice-on-late-filing-of-its-btw208hme44a.html

User Image Marcus2105 Posted - 04/17/24

$XCUR

User Image Marcus2105 Posted - 04/16/24

$XCUR

User Image ChartLaboratory_com Posted - 04/16/24

$XCUR potential reversal off the base $0.75 IS the breakout [MO] https://www.tradingview.com/x/I01GEQIS/

User Image UBER_ONE Posted - 04/16/24

$VHAI check inflow and o outflow. $2 is coming very soon. $WISA nice day guys $JAGX great run after FDA approval $XCUR Patent News Bullish

User Image AntKnee Posted - 04/16/24

$WISA Patent news on a beat up $XCUR Big uptick in volume.

User Image UBER_ONE Posted - 04/16/24

$PRZO $KALV MM Alert Patent listed $XCUR

User Image AntKnee Posted - 04/16/24

$XCUR Nice to see some Volume. Been quiet for too long.

User Image UBER_ONE Posted - 04/16/24

$DJT Patent Alarm $XCUR

User Image Eyesic Posted - 04/16/24

$XCUR me when my limit order hits at 1.00

User Image UBER_ONE Posted - 04/16/24

$XCUR

User Image AntKnee Posted - 04/16/24

$XCUR I’ve been patient, now let’s hurry!

User Image UBER_ONE Posted - 04/16/24

User Image UBER_ONE Posted - 04/16/24

$WISA Patent Alert $XCUR

User Image VrtcIl Posted - 04/16/24

Let's get that 1 on $XCUR. However, make sure to keep stop set and always protect your downside. Never blindly keep on holding, let the market dictate your decisions. Price: 0.73 Float: 4.1M Short Float: 2.9 % 💰 Dollar Volume: 18.0K ℹ️ USA | Biotechnology

User Image Wildblitz Posted - 04/16/24

$XCUR Did I call it earlier or get lucky?? GOOOOOOOOOOOOO!!!!!!!!!

User Image AlertsAndNews Posted - 04/16/24

$XCUR patent news here.

User Image US_Patent_Plays Posted - 04/16/24

$XCUR Granted US Patent #11957788 Today For "MULTIVALENT DELIVERY OF IMMUNE MODULATORS BY LIPOSOMAL SPHERICAL NUCLEIC ACIDS (FOR COMPLEX DISEASES SUCH AS CANCER AND ALLERGIES)". https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11957788

User Image Wildblitz Posted - 04/16/24

$XCUR Need some news--Lets Go

User Image Marcus2105 Posted - 04/15/24

$XCUR

Analyst Ratings
Chardan Capital Neutral Aug 16, 22